Interferon activity and its characterization in the sera of patients with head and neck cancer.

作者: Mitsunobu Sato , Hideo Yoshida , Tetsuo Yanagawa , Yoshiaki Yura , Mitsuru Urata

DOI: 10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

关键词: Beta-2 microglobulinCancerAntiserumInterferonImmunologyMedicineImmune systemLesionTiterHead and neck cancer

摘要: The interferon (IFN) assay of the sera from 40 patients with head and neck cancer was performed by plaque-reduction vesicular stomatitis virus in FL cells derived human amniotic membrane. mainly had Stage III or IV lesion without distant metastasis, previously not received any therapy. All were histologically diagnosed as squamous cell carcinoma. When serum IFN activity characterized acid treatment, significant increases IFN-α/β/γ (n = 24, P < 0.05) acid-labile 0.001), decrease acid-stable 0.001) 50-to-79-year age group found, compared those normal controls same 20). titers including various immunologic parameters simultaneously assayed prior to beginning therapy, IFN-α/β/γ, IFN, significantly correlated some such natural killer (NK) activity, absolute number Tγ lymphocytes, percentages β- γ-globulin, amounts IgA, IgG, IgM, β2 microglobulin. To define further nature this both donors a neutralization an antiserum HuIFN-α HUIFN-β. left when testing neutralized these antisera expressed γ-like IFN. 0.0001) showed highly increase correlation between prognosis disease investigated measuring patients, all nine good after treatment decreased levels (P 0.01) on time before On other hand, six recurrent measurement therapy 0.05). These findings led us suggest that levels, especially may be associated function loops immune system cancer.

参考文章(64)
John J Hooks, Barton F Haynes, Barbara Detrick-Hooks, Louis F Diehl, Theresa L Gerrard, Anthony S Fauci, None, Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease Blood. ,vol. 59, pp. 198- 201 ,(1982) , 10.1182/BLOOD.V59.1.198.198
Stefan Einhorn, Hans Strander, Interferon Therapy for Neoplastic Diseases in Man In Vitro and In Vivo Studies Advances in Experimental Medicine and Biology. ,vol. 110, pp. 159- 174 ,(1978) , 10.1007/978-1-4615-9080-4_13
Henric Blomgren, Kari Cantell, Bo Johansson, Curt Lagergren, Ulrik Ringborg, Hans Strander, Interferon therapy in Hodgkin's disease. A case report. Acta Medica Scandinavica. ,vol. 199, pp. 527- 532 ,(2009) , 10.1111/J.0954-6820.1976.TB06776.X
B J Grossmayer, H Ozer, J A O'Malley, D Sheedy, A Nussbaum-Blumenson, Identification of the T cell subset that produces human gamma interferon. Journal of Immunology. ,vol. 128, pp. 2522- 2526 ,(1982)
T. C. Merigan, M. B. Oldstone, Paolo Casali, B. Harfast, J. R. Huddlestone, Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. Journal of Immunology. ,vol. 127, pp. 2146- 2150 ,(1981)
J Vilcek, D Henriksen, S Panem, I J Check, Antibodies to alpha-interferon in a patient with systemic lupus erythematosus. Journal of Immunology. ,vol. 129, pp. 1- 3 ,(1982)
John J. Hooks, Abner L. Notkins, Takashi Fujibayashi, Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes. Journal of Immunology. ,vol. 115, pp. 1191- 1193 ,(1975)
A D Bankhurst, W L Sibbitt, M A Rodriguez, W A Prinz, R C Williams, alpha-Interferon increases immunoglobulin production in cultured human mononuclear leukocytes. Journal of Immunology. ,vol. 130, pp. 1215- 1219 ,(1983)
Hiroaki Mitsuya, Shinhachiro Tomino, Masahide Kuroki, Taro Saito, Shoji Kotegawa, Susumu Kishimoto, Shotaro Hisamitsu, Koichiro Inomata, Age-related changes in the subsets and functions of human T lymphocytes Journal of Immunology. ,vol. 121, pp. 1773- 1780 ,(1978)